Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Oct 14;26(7):taz064.
doi: 10.1093/jtm/taz064.

'More than devastating'-patient experiences and neurological sequelae of Japanese encephalitis§

Affiliations
Case Reports

'More than devastating'-patient experiences and neurological sequelae of Japanese encephalitis§

Lance Turtle et al. J Travel Med. .

Abstract

Background: Japanese encephalitis (JE), caused by the mosquito-borne JE virus, is a vaccine-preventable disease endemic to much of Asia. Travellers from non-endemic areas are susceptible if they travel to a JE endemic area. Although the risk to travellers of JE is low, the consequences may be severe.

Methods: Here, we describe three cases of JE in British travellers occurring in 2014-15. In addition, we report, through interviews with survivors and their families, personal experiences of life after JE.

Results: Three cases of JE were diagnosed in British travellers in 2014/15. One was acquired in Thailand, one in China and one in either Thailand, Laos or Cambodia. All three patients suffered severe, life-threatening illnesses, all were admitted to intensive care units and required medical evacuation back to the UK. One patient suffered a cardiac arrest during the acute stage but made a good recovery. The other two patients remain significantly paralysed and ventilator dependent. All three cases had clear indications for vaccination, and all have been left with life-changing neurological sequelae.

Conclusions: Travel health providers should be aware of the severity of JE, as well as the risk, allowing travellers to make fully informed decisions on JE vaccination.

Keywords: JE; JE vaccine; JE virus; Japanese encephalitis; Japanese encephalitis vaccine; Travel medicine; Traveller.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Map of the travel destination of the three cases, including medical evacuation routes within Asia
Figure 2
Figure 2
Neurological imaging of Patient two. (A), MRI scan performed in Bangkok on 18 July 2015 showing bilateral thalamic lesions, worse on the right (arrow). (B and C), MRI scan in Liverpool on 4 August 2015 showing persistent thalamic lesions (B, arrow) and high signal in the spinal cord (C, arrow)
Figure 3
Figure 3
MRI of Patient three. (A), FLAIR images from an MRI scan performed in Bangkok on 5 August 2015 showing symmetrical high signal affecting the thalami and lentiform nuclei bilaterally. Evidence of radiosurgery to the left basal ganglia arteriovenous malformation with associated encephalomalacia within the left cerebral white matter and some haemosiderin deposition from the arteriovenous malformation is seen. (B), The abnormal area extends into the medial temporal lobes, the cerebral peduncles and into the brain stem

Similar articles

Cited by

References

    1. Grossman RA, Edelman R, Willhight M et al. . Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. 3. Human seroepidemiology and inapparent infections. Am J Epidemiol 1973; 98:133–49. - PubMed
    1. Halstead SB, Grosz CR. Subclinical Japanese encephalitis. I. Infection of Americans with limited residence in Korea. Am J Hyg 1962; 75:190–201. - PubMed
    1. Connor BA, Hamer DH, Kozarsky P et al. . Japanese encephalitis vaccine for travelers: risk-benefit reconsidered. J Travel Med 2019:26, pii. taz037. doi:10.1093/jtm/taz037. - PubMed
    1. Nealon J, Taurel AF, Yoksan S et al. . Serological evidence of Japanese encephalitis virus circulation in Asian children from dengue-endemic countries. J Infect Dis 2019; 219:375–81. - PMC - PubMed
    1. Hegde NR, Gore MM. Japanese encephalitis vaccines: immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease. Hum Vaccin Immunother 2017; 22:1–18. - PMC - PubMed

Publication types

Substances